Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PM54 in Combination With Cytotoxic and Targeted Agents for Advanced Solid Tumors
NCT07839819Phase 2Not yet recruiting
- Sponsor
- PharmaMar
- Start
- Nov 2026
- Primary completion
- Sep 2029
- Countries
- 4
01
Overview
A Phase 2 trial of PM54 in solid tumor (advanced stage), sponsored by PharmaMar. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
PM54
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT07839819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07839819.